Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis CLOV

Max Ratio

Dividend Yield

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History CLOV

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield
Consecutive Years 0
Forward Annual Dividend – USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends 0
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.
Dividend Policy i

Sales Growth CLOV

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin CLOV

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income CLOV

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM CLOV

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio CLOV

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Clover Health Investments Corp CLOV

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself CLOV

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE 81.97
Enterprise Value Revenue 1.10
Price Sales TTM 1.19
Enterprise Value EBITDA -0.65
Price Book MRQ 8.16

Clover Health Investments Corp

CLOV
Current price
4.82 USD +0.18 USD (+3.88%)
Last closed 4.68 USD
ISIN US18914F1030
Sector Healthcare
Industry Healthcare Plans
Exchange NASDAQ
Capitalization 2 633 421 568 USD
Yield for 12 month +61.74 %
1Y
3Y
5Y
10Y
15Y
CLOV
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+1 924 308 000 USD

Last Year

+1 371 131 000 USD

Current Quarter

+749 189 000 USD

Last Quarter

+487 707 000 USD

Current Year

+355 882 000 USD

Last Year

+364 804 000 USD

Current Quarter

+159 541 000 USD

Last Quarter

+74 207 000 USD
EBITDA -56 686 000 USD
Operating Margin TTM 3.65 %
Price to Earnings
Return On Assets TTM -5.55 %
PEG Ratio
Return On Equity TTM -16.86 %
Wall Street Target Price 4.15 USD
Revenue TTM 2 210 365 952 USD
Book Value 0.65 USD
Revenue Per Share TTM 4.27 USD
Dividend Share
Quarterly Revenue Growth YOY 62.00 %
Dividend Yield
Gross Profit TTM 405 753 984 USD
Earnings per share -0.12 USD
Diluted Eps TTM -0.12 USD
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY
Profit Margin -2.58 %
Price to Free Cash Flow TTM 36.11

Technical Indicators CLOV

For 52 Weeks

1.58 USD 5.59 USD
50 Day MA 3.96 USD
Shares Short Prior Month 28 596 652
200 Day MA 2.83 USD
Short Ratio 2.66
Shares Short 24 851 129
Short Percent 5.98 %